161 related articles for article (PubMed ID: 35697299)
1. TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
Verma M; Loh NY; Sabaratnam R; Vasan SK; van Dam AD; Todorčević M; Neville MJ; Toledo E; Karpe F; Christodoulides C
Metabolism; 2022 Aug; 133():155240. PubMed ID: 35697299
[TBL] [Abstract][Full Text] [Related]
2.
Justesen L; Ribel-Madsen R; Gillberg L; Hansen NS; Wulff AL; Grunnet LG; Brøns C
Endocr Res; 2019 Aug; 44(3):110-116. PubMed ID: 30721637
[No Abstract] [Full Text] [Related]
3. The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
Chen X; Ayala I; Shannon C; Fourcaudot M; Acharya NK; Jenkinson CP; Heikkinen S; Norton L
Diabetes; 2018 Apr; 67(4):554-568. PubMed ID: 29317436
[TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.
Geoghegan G; Simcox J; Seldin MM; Parnell TJ; Stubben C; Just S; Begaye L; Lusis AJ; Villanueva CJ
Mol Metab; 2019 Jun; 24():44-63. PubMed ID: 30948248
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice.
Nguyen-Tu MS; Martinez-Sanchez A; Leclerc I; Rutter GA; da Silva Xavier G
Diabetologia; 2021 Jan; 64(1):129-141. PubMed ID: 33068125
[TBL] [Abstract][Full Text] [Related]
6. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.
Savic D; Ye H; Aneas I; Park SY; Bell GI; Nobrega MA
Genome Res; 2011 Sep; 21(9):1417-25. PubMed ID: 21673050
[TBL] [Abstract][Full Text] [Related]
7. Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes.
Chen ZL; Shao WJ; Xu F; Liu L; Lin BS; Wei XH; Song ZL; Lu HG; Fantus IG; Weng JP; Jin TR
Cell Signal; 2015 Mar; 27(3):587-97. PubMed ID: 25550093
[TBL] [Abstract][Full Text] [Related]
8. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
9. The rs7903146 Variant in the
Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes.
Pang DX; Smith AJ; Humphries SE
Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):550-6. PubMed ID: 22402060
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes.
Prokunina-Olsson L; Kaplan LM; Schadt EE; Collins FS
PLoS One; 2009 Sep; 4(9):e7231. PubMed ID: 19789636
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic Risk Scores.
Corella D; Coltell O; Sorlí JV; Estruch R; Quiles L; Martínez-González MÁ; Salas-Salvadó J; Castañer O; Arós F; Ortega-Calvo M; Serra-Majem L; Gómez-Gracia E; Portolés O; Fiol M; Díez Espino J; Basora J; Fitó M; Ros E; Ordovás JM
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27929407
[TBL] [Abstract][Full Text] [Related]
13. TCF7L2 genetic defect and type 2 diabetes.
Cauchi S; Froguel P
Curr Diab Rep; 2008 Apr; 8(2):149-55. PubMed ID: 18445358
[TBL] [Abstract][Full Text] [Related]
14. Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2.
Howard EW; Been LF; Lerner M; Brackett D; Lightfoot S; Bullen EC; Sanghera DK
BMC Genet; 2013 Apr; 14():28. PubMed ID: 23617586
[TBL] [Abstract][Full Text] [Related]
15. The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.
Sgariglia F; Pedrini E; Bradfield JP; Bhatti TR; D'Adamo P; Dormans JP; Gunawardena AT; Hakonarson H; Hecht JT; Sangiorgi L; Pacifici M; Enomoto-Iwamoto M; Grant SF
Bone; 2015 Mar; 72():123-7. PubMed ID: 25498973
[TBL] [Abstract][Full Text] [Related]
16. The role of transcription factor 7-like 2 in metabolic disorders.
Zhang Z; Xu L; Xu X
Obes Rev; 2021 May; 22(5):e13166. PubMed ID: 33615650
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptional and posttranslational transcription factor 7-like regulation among nondiabetic individuals and type 2 diabetic patients.
Pradas-Juni M; Nicod N; Fernández-Rebollo E; Gomis R
Mol Endocrinol; 2014 Sep; 28(9):1558-70. PubMed ID: 25058603
[TBL] [Abstract][Full Text] [Related]
19. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
Drake I; Wallström P; Hindy G; Ericson U; Gullberg B; Bjartell A; Sonestedt E; Orho-Melander M; Wirfält E
Prostate; 2014 Sep; 74(12):1161-70. PubMed ID: 24961829
[TBL] [Abstract][Full Text] [Related]
20. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
Pereira MJ; Vranic M; Kamble PG; Jernow H; Kristófi R; Holbikova E; Skrtic S; Kullberg J; Svensson MK; Hetty S; Eriksson JW
Transl Res; 2022 Apr; 242():105-121. PubMed ID: 34896253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
